TY - JOUR
T1 - Pregnancies and Time to Pregnancy in Women With and Without a Previous Chlamydia trachomatis Infection
AU - Hoenderboom, Bernice M.
AU - van Bergen, Jan E. A. M.
AU - Dukers-Muijrers, Nicole H. T. M.
AU - Götz, Hannelore M.
AU - Hoebe, Christian J. P. A.
AU - de Vries, Henry J. C.
AU - van den Broek, Ingrid V. F.
AU - de Vries, Frank
AU - Land, Jolande A.
AU - van der Sande, Marianne A. B.
AU - Morré, Servaas A.
AU - van Benthem, Birgit H. B.
N1 - Funding Information: From the *Epidemiology and Surveillance Unit, Centre for Infectious Dis-ease Control, National Institute for Public Health and the Environment, Bilthoven; †Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, Amsterdam UMC, Location VU Medical Center; ‡Department of General Practice, Division Clinical Methods and Public Health, Academic Medical Center; §STI AIDS Netherlands (SOA AIDS Nederland), Amsterdam; ¶Department of Sex-ual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service (GGD South Limburg), Geleen; ||Department of Social Medicine and Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht; **De-partment of Infectious Disease Control, Municipal Public Health Ser-vice Rotterdam-Rijnmond (GGD Rotterdam); ††Department of Public Health, Erasmus MC—University Medical Center Rotterdam, Rotterdam; ‡‡Department of Dermatology, Amsterdam Institute for Infection and Immunity (AI&II), University of Amsterdam, Amsterdam UMC, Loca-tion Academic Medical Centre; §§STI Outpatient Clinic, Department of Infectious Diseases, Public Health Service Amsterdam; ¶¶Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Heerlen; ||||Department of Clinical Phar-macy and Toxicology, ***CARIM, School for Cardiovascular Diseases, Maastricht UMC+; †††Department of Genetics and Cell Biology, Re-search School GROW (School for Oncology and Developmental Bi-ology), Faculty of Health, Medicine and Life Sciences, University of Maastricht, Maastricht; ‡‡‡Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; and §§§Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium Conflict of Interest and Sources of Funding: The authors declare no conflict of interest. This work was supported by the Netherlands Organisation for Health Research and Development (ZonMW Netherlands; a govern-mental organization (grant registration number: 50-53000-98-103) and Research Funding from the Ministry of Health, Welfare and Sports to the Centre of Infectious Disease Control. The funders had no role in study design, data collection and analysis, interpretation of data, deci-sion to publish, or preparation of the manuscript. Publisher Copyright: Copyright © 2020 American Sexually Transmitted Diseases Association. All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Background: AChlamydia trachomatis infection (chlamydia) can result in tubal factor infertility in women. To assess if this association results in fewer pregnant women, we aimed to assess pregnancy incidences and time to pregnancy among women with a previous chlamydia infection compared with women without one and who were participating in the Netherlands Chlamydia Cohort Study (NECCST). Methods: The NECCST is a cohort of women of reproductive age tested for chlamydia in a chlamydia screening trial between 2008 and 2011 and reinvited for NECCST in 2015 to 2016. Chlamydia status (positive/negative) was defined using chlamydia screening trial-nucleic acid amplification test results, chlamydia immunoglobulin G presence in serum, or self-reported chlamydia infections. Data on pregnancies were collected via questionnaires in 2015-2016 and 2017-2018. Overall pregnancies (i.e., planned and unplanned) and time to pregnancy (among women with a pregnancy intention) were compared between chlamydia-positive and chlamydia-negative women using Cox regressions. Results: Of 5704 women enrolled, 1717 (30.1%; 95% confidence interval [CI], 28.9-31.3) women was chlamydia positive. Overall pregnancy proportions were similar in chlamydia-positive and chlamydia-negative women (49.0% [95%CI, 46.5-51.4] versus 50.5%[95%CI, 48.9-52.0]). Pregnancies per 1000 person-years were 53.2 (95% CI, 51.5-55.0) for chlamydia negatives and 83.0 (95% CI, 78.5-87.9) for chlamydia positives. Among women with a pregnancy intention, 12% of chlamydia-positive women had a time to pregnancy of >12 months compared with 8% of chlamydia negatives (P < 0.01). Conclusions: Overall pregnancy rates were not lower in chlamydia-positive women compared with chlamydia-negative women, but among women with a pregnancy intention, time to pregnancy was longer and pregnancy rates were lower in chlamydia-positive women.
AB - Background: AChlamydia trachomatis infection (chlamydia) can result in tubal factor infertility in women. To assess if this association results in fewer pregnant women, we aimed to assess pregnancy incidences and time to pregnancy among women with a previous chlamydia infection compared with women without one and who were participating in the Netherlands Chlamydia Cohort Study (NECCST). Methods: The NECCST is a cohort of women of reproductive age tested for chlamydia in a chlamydia screening trial between 2008 and 2011 and reinvited for NECCST in 2015 to 2016. Chlamydia status (positive/negative) was defined using chlamydia screening trial-nucleic acid amplification test results, chlamydia immunoglobulin G presence in serum, or self-reported chlamydia infections. Data on pregnancies were collected via questionnaires in 2015-2016 and 2017-2018. Overall pregnancies (i.e., planned and unplanned) and time to pregnancy (among women with a pregnancy intention) were compared between chlamydia-positive and chlamydia-negative women using Cox regressions. Results: Of 5704 women enrolled, 1717 (30.1%; 95% confidence interval [CI], 28.9-31.3) women was chlamydia positive. Overall pregnancy proportions were similar in chlamydia-positive and chlamydia-negative women (49.0% [95%CI, 46.5-51.4] versus 50.5%[95%CI, 48.9-52.0]). Pregnancies per 1000 person-years were 53.2 (95% CI, 51.5-55.0) for chlamydia negatives and 83.0 (95% CI, 78.5-87.9) for chlamydia positives. Among women with a pregnancy intention, 12% of chlamydia-positive women had a time to pregnancy of >12 months compared with 8% of chlamydia negatives (P < 0.01). Conclusions: Overall pregnancy rates were not lower in chlamydia-positive women compared with chlamydia-negative women, but among women with a pregnancy intention, time to pregnancy was longer and pregnancy rates were lower in chlamydia-positive women.
UR - http://www.scopus.com/inward/record.url?scp=85092944233&partnerID=8YFLogxK
U2 - https://doi.org/10.1097/OLQ.0000000000001247
DO - https://doi.org/10.1097/OLQ.0000000000001247
M3 - Article
C2 - 32701764
SN - 0148-5717
VL - 47
SP - 739
EP - 747
JO - Sexually transmitted diseases
JF - Sexually transmitted diseases
IS - 11
ER -